How many days does avatrombopag (Su Kexin) take to increase platelets and take effect?

Avatrombopag , trade name Sucoxin, is an oral thrombopoietin receptor agonist (TPO-RA). It is an innovative drug produced by Eisai Co., Ltd. of Japan. It is mainly used to treat thrombocytopenia related to chronic liver disease (CLD). It is also the first domestic treatment drug for this disease. In addition, avatrombopag also has application potential in the fields of tumor chemotherapy-induced thrombocytopenia (CIT) and immune thrombocytopenia (ITP).

The time it takes for platelets to rise after avatrombopag varies depending on the patient's specific circumstances. Generally speaking, some patients may begin to feel improvement in symptoms within 3 days, such as reduced fatigue or increased physical strength. However, for patients with more severe liver disease or more obvious thrombocytopenia, it may take longer to see significant platelet-raising effects, usually 5 days or even longer.

In clinical trials, avatrombopag has been shown to produce rapid increases in platelets after administration and to achieve sustained responses. However, the specific response time depends on individual patient differences and the severity of the condition.

Avatrombopag, as an innovative drug, provides a new treatment option for patients with thrombocytopenia. The time it takes to take effect in increasing platelets varies from individual to individual, but a certain effect can usually be seen within a few days. When using avatrombopag, patients should follow their doctor's recommendations and prescriptions and regularly monitor platelet levels to ensure the effectiveness and safety of the treatment.